What is Pfizer's long-term marketable securities?

Pfizer (PFE) reported long-term marketable securities of $0.00 in Q1 2026.

What does long-term marketable securities mean?

Long-term investments in debt securities held for interest income.

Long-term marketable securities

Pfizer Long-term marketable securities decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ4 2025

Last reportedQ1 2026

How to read this metric

An increase indicates a long-term capital preservation strategy, while a decrease suggests the liquidation of long-term investments to fund operations or debt repayment.

Detailed definition

This represents long-term investments in debt securities that the company intends to hold for more than one year. These...

Peer comparison

Used by mature companies with strong cash flows to manage long-term liquidity and investment returns.

Metric ID: non_current_assets_available_for_sale_securities_debt_se_908f76

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$1.00M	$0.00
QoQ Change	—	-100.0%

Range$0.00 – $1.00M

Long-term marketable securities at Other Companies

BiogenBIIB View metric

Frequently Asked Questions

What is Pfizer's long-term marketable securities?: Pfizer (PFE) reported long-term marketable securities of $0.00 in Q1 2026.
What does long-term marketable securities mean?: Long-term investments in debt securities held for interest income.